Baltimore, MD, United States of America

Pascal Acree

This inventor holds 1 USPTO granted patent. Top assignee: Johns Hopkins University. Active years: 2025.


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Pascal Acree

Introduction

Pascal Acree is a notable inventor based in Baltimore, MD (US). He has made significant strides in the field of cryotherapy, particularly with his innovative approach to treating tumorous masses. His work is characterized by a commitment to advancing medical technology and improving patient outcomes.

Latest Patents

Acree holds a patent for a "Carbon dioxide-based percutaneous cryosurgical system." This invention features a handheld cryoprobe designed for use in percutaneous cryotherapy. The system includes a probe attached to a CO2 gas dispensing backend, optimized for effective heat exchange. The backend regulates the flow of compressed CO2 while cooling the gas to cytotoxically low temperatures necessary for targeted tumor cell death. The design incorporates a Joule-Thomson nozzle that enhances the cooling process, creating a positive feedback loop that continually decreases the gas's temperature at the probe tip.

Career Highlights

Pascal Acree is affiliated with Johns Hopkins University, where he contributes to research and development in medical technologies. His work has garnered attention for its innovative approach to cryotherapy, showcasing his dedication to improving surgical techniques and patient care.

Collaborations

Acree collaborates with talented individuals such as Bailey Surtees and Evelyn McChesney. Their combined expertise fosters an environment of innovation and progress in their respective fields.

Conclusion

Pascal Acree's contributions to the field of cryotherapy exemplify the impact of innovative thinking in medicine. His patented technology represents a significant advancement in the treatment of tumors, highlighting the importance of research and collaboration in developing effective medical solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…